Developer of a synthetic glucose-binding molecule designed for glucose sensing applications. The company's technology is a selective synthetic receptor for glucose that is produced through a streamlin...

Healthcare
Bristol, United Kingdom
Founded 2018
16 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$13.8M
Last Round
N/A